Tumor necrosis factor induces tumor necrosis via tumor necrosis factor receptor type 1-expressing endothelial cells of the tumor vasculature

被引:62
作者
Stoelcker, B
Ruhland, B
Hehlgans, T
Bluethmann, H
Luther, T
Männel, DN [1 ]
机构
[1] Univ Regensburg, Inst Pathol Tumor Immunol, Dept Pathol, D-93042 Regensburg, Germany
[2] F Hoffmann La Roche & Co Ltd, Pharmaceut Res Gene Technol, CH-4002 Basel, Switzerland
[3] Tech Univ Dresden, Inst Pathol, D-8027 Dresden, Germany
关键词
D O I
10.1016/S0002-9440(10)64986-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Activation of endothelial cells, fibrin deposition, and coagulation within the tumor vasculature has been shown in vivo to correlate with the occurrence of tumor necrosis factor (TNF)-induced tumor necrosis in mice. In the present study we investigated which target cells mediate the TNF-induced necrosis in fibrosarcomas grown in wild type (wt), TNF receptor type I-deficient (TNFRp55-/-), and TNF receptor type 2-deficient (TNFRp75-/-) mice. TNF administration resulted in tumor necrosis exclusively in wt and TNFRp75-/-, but not in TNFRp55 -/- mice, indicating a dependence of TNF-mediated tumor necrosis on the expression of TNF receptor type 1, However, using wt and TNFRp55-/- fibrosarcomas in wt mice, we found that TNF-mediated tumor necrosis was completely independent of TNF receptor type 1 expression in tumor cells. Thus we could exclude any direct tumoricidal effect of TNF in this model. Soluble TNF induced leukostasis in wt and TNFRp75-/- mice but not in TNFRp55-/- mice. TNF-induced leukostasis in TNFRp55-/- mice was restored by adoptive bone marrow transplantation of wt hematopoietic cells, but TNF failed to induce tumor necrosis in these chimeric mice. Because TNF administration resulted in both activation and focal damage of tumor endothelium, TNF receptor type 1-expressing cells of the tumor vasculature, likely to be endothelial cells, appear to be target cells for mediating TNF-induced tumor necrosis.
引用
收藏
页码:1171 / 1176
页数:6
相关论文
共 28 条
[1]   MECHANISM OF THE TUMOR-NECROSIS-FACTOR ALPHA-MEDIATED INDUCTION OF ENDOTHELIAL TISSUE FACTOR [J].
BIERHAUS, A ;
ZHANG, YM ;
DENG, YH ;
MACKMAN, N ;
QUEHENBERGER, P ;
HAASE, M ;
LUTHER, T ;
MULLER, M ;
BOHRER, H ;
GRETEN, J ;
MARTIN, E ;
BAEUERLE, PA ;
WALDHERR, R ;
KISIEL, W ;
ZIEGLER, R ;
STERN, DM ;
NAWROTH, PP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26419-26432
[2]   ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[3]  
CHANG SW, 1994, J LAB CLIN MED, V123, P65
[4]  
Ditter B, 1982, Prog Clin Biol Res, V93, P385
[5]   DECREASED SENSITIVITY TO TUMOR-NECROSIS-FACTOR BUT NORMAL T-CELL DEVELOPMENT IN TNF RECEPTOR-2-DEFICIENT MICE [J].
ERICKSON, SL ;
DESAUVAGE, FJ ;
KIKLY, K ;
CARVERMOORE, K ;
PITTSMEEK, S ;
GILLETT, N ;
SHEEHAN, KCF ;
SCHREIBER, RD ;
GOEDDEL, DV ;
MOORE, MW .
NATURE, 1994, 372 (6506) :560-563
[6]   REGULATION OF TISSUE FACTOR GENE-EXPRESSION IN THE MONOCYTE PROCOAGULANT RESPONSE TO ENDOTOXIN [J].
GREGORY, SA ;
MORRISSEY, JH ;
EDGINGTON, TS .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (06) :2752-2755
[7]   Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature [J].
Huang, XM ;
Molema, G ;
King, S ;
Watkins, L ;
Edgington, TS ;
Thorpe, PE .
SCIENCE, 1997, 275 (5299) :547-550
[8]   Distribution of von Willebrand factor in capillary endothelial cells of rat lungs with pulmonary fibrosis [J].
Kasper, M ;
Schobl, R ;
Haroske, G ;
Fischer, R ;
Neubert, F ;
Dimmer, V ;
Muller, M .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1996, 48 (04) :283-288
[9]   Clinical applications of TNF-α in cancer [J].
Lejeune, FJ ;
Rüegg, C ;
Liénard, D .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) :573-580
[10]   Tissue factor expression during coculture of endothelial cells and monocytes [J].
Lewis, JC ;
Jones, NL ;
Hermanns, MI ;
Rohrig, O ;
Klein, CL ;
Kirkpatrick, CJ .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1995, 62 (03) :207-218